Decreased serum heat shock protein 60 levels in newly diagnosed immune thrombocytopenia patients

Platelets

Volumn 26, Issue 3, 2015, Pages 220-223

  Dolasik, Ilhan ^a   Birtas Atesoglu, Elif ^a   Tarkun, Pinar ^a   Mehtap, Ozgur ^a   Keski, Hakan ^a   Dogru, Atalay ^a   Hacihanefioglu, Abdullah ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Heat shock proteins; HSP60; HSP70; Immune thrombocytopenia; ITP

Indexed keywords

CHAPERONIN 60; HEAT SHOCK PROTEIN 70; AUTOANTIBODY; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLOOD CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THROMBOCYTE COUNT; BLOOD; CASE CONTROL STUDY; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BIOMARKERS; CASE-CONTROL STUDIES; CHAPERONIN 60; FEMALE; FOLLOW-UP STUDIES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PROGNOSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLENECTOMY; YOUNG ADULT;

EID: 84925936633     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2014.898746     Document Type: Article

References (29)

1. Stasi R. Pathophysiology and therapeutic options in primary immune thrombocytopenia. Blood Transfus 2011;9:262-273.
2. Semple JW, Provan D. The immunopathogenesis of immune thrombocytopenia: T cells still take center-stage. Curr Opin Hematol 2012;19:357-362.
3. Ellis RJ, Van Der Vies SM. Molecular chaperones. Annu Rev Biochem 1991;600:321-347.
4. Xiao C, Chen S, Yuan M, et al. Expression of the 60 kDa and 71 kDa heat shock proteins and presence of antibodies against the 71 kDa heat shock protein in pediatric patients with immune thrombocytopenic purpura. BMC Blood Disord 2004;4:1-10.
5. Rajaiah R, Moudgil KD. Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 2009;8:388-393.
6. Pockley AG, Muthana M, Calderwood SK. The dual immunoregulatory roles of stress proteins. Trends Biochem Sci 2008;33:71-79.
7. Calderwood SK, Mambula SS, Gray Jr PJ. Extracellular heat shock proteins in cell signaling and immunity. Ann N Y Acad Sci 2007; 1113:28-39.
8. Mor F, Cohen IR. T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins. J Clin Invest 1992;90:2447-2455.
9. Yin Ji X, Kang MR, Choi JS, Jeon HS, Han HS, Kim JY, Son BR, Lee YM, Hahn YS. Levels of intra-and extracellular heat shock protein 60 in Kawasaki disease patients treated with intravenous immunoglobulin. Clin Immunol. 2007;124:304-10.
10. Imamura Y, Kurokawa MS, Yoshikawa H, et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol 2005; 139:371-378.
11. Delaleu N, Madureira AC, Immervoll H, Jonsson R. Inhibition of experimental Sjogren's syndrome through immunization with HSP60 and its peptide amino acids 437-460. Arthritis Rheum 2008;58:2318-2328.
12. Hayem G, De Bandt M, Palazzo E, Roux S, Combe B, Eliaou JF, Sany J, Kahn MF, Meyer O. Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis 1999;58:291-296.
13. Birtas-Atesoglu E, Inanc N, Yavuz S, Ergun T, Direskeneli H. Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behcęt's disease. Clin Exp Rheumatol 2008;26:96-98.
14. Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168-186.
15. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group. Blood 2009;113:2386-2393.
16. Weaver CT, Hatton RD. Interplay between the TH17 and TReg cell lineages: a co-evolutionary perspective. Nat Rev Immunol 2009;9: 883-889.
17. Tesmer LA. Th17 cells in human disease. Immunol Rev 2008;223: 87-113.
18. David R. Regulatory T cells: fine-tuning TReg cells. Nat Rev Immunol 2009;9:226-227.
19. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010;10:490-500.
20. Nishimoto T, Satoh T, Takeuchi T, Ikeda Y, Kuwana M. Critical role of CD4(+)CD25(+) regulatory T cells in preventing murine autoantibody-mediated thrombocytopenia. Exp Hematol 2012;40: 279-89.
21. Lamb JR, Bal V, Mendez-Samperio P, Mehlert A, So A, Rothbard J, Jindal S, Young RA, Young DB. Stress proteins may provide a link between the immune response to infection and autoimmunity. Int Immunol 1989;1:191-196.
22. Van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005; 5:318-330.
23. Wieten L, Broere F, van der Zee R, Koerkamp EK, Wagenaar J, van Eden W. Cell stress induced HSP are targets of regulatory T cells: A role for HSP inducing compounds as anti-inflammatory immuno-modulators? FEBS Lett 2007;581:3716-3722.
24. van Roon JA, van Eden W, van Roy JL, Lafeber FJ, Bijlsma JW. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1997;100:459-463.
25. Binder R.J, Vatner R, Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 2004;64: 442-451.
26. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197:403-411.
27. Ling Y, Cao X, Yu Z, Ruan C. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome. Eur J Hematol 2007;79:310-316.
28. Liu B, Zhao H, Poon MC, Han Z, Gu D, Xu M, Jia H, Yang R, Han ZC. Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol 2007;78: 139-143.
29. Teke Hü, Gündüz E, Akay OM, Gülbas Z. Abnormality of regulatory T-cells in remission and non-remission idiopathic thrombocytopaenic purpura patients. Platelets 2013;24:625-631.